
Startups & growth Analysis
CpG Diagnostics develops a blood test for a difficult ovarian-mass decision
CpG Diagnostics is developing OvaPrint to help clinicians assess an ovarian-area mass before treatment, with clinical validation underway.

MoneyMakers coverage
Page 1 of 1 · 1 report
Founder and CEO of CpG Diagnostics.
Published reporting on Bodour Salhia. Entries describe developments as reported on their publication dates.